Drug Pipeline

Standard of Care Chemotherapy Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
6
Active Studies
3
Recruiting
3
Phase 3
6
Top Sponsors
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-05 NCT07578649
Symbiotic-GYN-18: A Study to Learn About the Study Medicine Called PF-08634404 in…		 Trial sites expanded: 0 -> 4 locations
2026-05-16 NCT07001748
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With…		 Trial sites expanded: 10 -> 55 locations
Active Studies by Phase
Phase 3
2
Phase 2/3
1
Phase 2
1
Phase 1
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06937905 Tarlatamab vs Standard of Care Chemotherapy in Patients With Pre-treated Advanced… Neuroendocrine Carcinoma Recruiting
NCT07578649 Symbiotic-GYN-18: A Study to Learn About the Study Medicine Called PF-08634404 in… Endometrial Neoplasms Not Yet Recruiting
Phase 2/3
NCT07001748 Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With… Gastric Adenocarcinoma Recruiting
Phase 2
NCT04620187 Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas Salivary Gland Cancer Recruiting
Phase 1
NCT03313778 Safety, Tolerability, and Immunogenicity of mRNA-4157 Alone and in Combination in… Solid Tumors Active, Not Recruiting
Not specified
NCT06480773 Kaposi Sarcoma Chemotherapy and Research (KS-CARE) Kaposi Sarcoma Active, Not Recruiting
Sponsors Running Standard of Care Chemotherapy Trials
ModernaTX, Inc. (1) Dana-Farber Cancer Institute (1) UNC Lineberger Comprehensive Cancer Center (1) Intergroupe Francophone de Cancerologie Thoracique (1) ECOG-ACRIN Cancer Research Group (1) Pfizer (1)
Disease Areas
Sarcoma (1) Endometrial Cancer (1)
Get alerts when Standard of Care Chemotherapy trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free